eFFECTOR Therapeutics, Inc.
EFTRDelisted Jul 19, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001828522
eFFECTOR Therapeutics, Inc. was delisted on Jul 19, 2024; its insiders filed their last Form 4 on Jun 13, 2024; 18 institutions reported holding it in 13F filings for Q2 2024, worth $251.1K in total; no superinvestor held it.
13F holders, Q2 2022
Institutional positions in eFFECTOR Therapeutics, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 24
- +5 vs. Q1 2022
- Shares held
- 24.1M
- +1.64M (+7.3%) vs. Q1 2022
- Total value
- $33.9M
- −$55.9M (−62.3%) vs. Q1 2022
- New holders
- 7
- 8 more added
- Sold out
- 2
- 1 more reduced
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EFTR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $0 |
| Q1 2026 | 1 | $0 |
| Q4 2025 | 1 | $0 |
| Q3 2025 | 1 | $0 |
| Q2 2025 | 1 | $0 |
| Q1 2025 | 1 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 3 | $4.33K |
| Q2 2024 | 18 | $251.1K |
| Q1 2024 | 17 | $13.5M |
| Q4 2023 | 24 | $5.44M |
| Q3 2023 | 29 | $14.0M |
| Q2 2023 | 33 | $20.2M |
| Q1 2023 | 26 | $8.29M |
| Q4 2022 | 30 | $10.4M |
| Q3 2022 | 27 | $13.7M |
| Q2 2022 | 24 | $33.9M |
| Q1 2022 | 19 | $89.7M |
| Q4 2021 | 18 | $174.2M |
| Q3 2021 | 12 | $187.9M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding eFFECTOR Therapeutics, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 66 | $0 | 0.00% | +6+10.0% | Added |
| Simplex Trading, LLC | 141 | $0 | 0.00% | +141 | New |
| Advisor Group Holdings, Inc. | 1,500 | $2.00K | 0.00% | +1,500 | New |
| Penserra Capital Management LLC | 5,108 | $7.00K | 0.00% | +1,488+41.1% | Added |
| Morgan Stanley | 7,249 | $10.0K | 0.00% | +7,188+11,783.6% | Added |
| Tower Research Capital LLC (TRC) | 7,478 | $11.0K | 0.00% | +6,930+1,264.6% | Added |
| Virtu Financial LLC | 15,667 | $22.0K | 0.00% | +15,667 | New |
| BlackRock Inc. | 16,699 | $24.0K | 0.00% | +15,566+1,373.9% | Added |
| Callan Capital, LLC | 20,000 | $28.0K | 0.00% | +20,000 | New |
| State Street Corp | 20,085 | $29.0K | 0.00% | +3,085+18.1% | Added |
| Northern Trust Corp | 25,993 | $37.0K | 0.00% | +9,248+55.2% | Added |
| Renaissance Technologies LLC | 29,288 | $42.0K | 0.00% | +29,288 | New |
| Resolute Financial, LLC | 30,000 | $43.0K | 0.04% | +30,000 | New |
| Geode Capital Management, LLC | 106,346 | $151.0K | 0.00% | 00.0% | Unchanged |
| Norges Bank | 416,300 | $591.1K | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 516,798 | $734.0K | 0.00% | 00.0% | Unchanged |
| Evolution Capital Management LLC | 527,885 | $750.0K | 1.12% | +527,885 | New |
| OUP Management Co., LLC | 1,025,697 | $1.46M | 2.00% | 00.0% | Unchanged |
| Blackstone Group Inc. | 1,308,587 | $1.86M | 0.01% | 00.0% | Unchanged |
| Parallel Advisors, LLC | 1,693,559 | $2.40M | 0.11% | +1,016,107+150.0% | Added |
| Sectoral Asset Management Inc | 2,382,644 | $3.38M | 0.68% | −1000.0% | Reduced |
| The Column Group LLC | 4,309,329 | $6.12M | 1.30% | 00.0% | Unchanged |
| Abingworth LLP | 4,822,114 | $6.46M | 2.07% | 00.0% | Unchanged |
| Sr One Capital Management, LP | 6,822,114 | $9.69M | 4.74% | 00.0% | Unchanged |
| Alps Advisors Inc | 0 | $0 | 0.00% | −46,537−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −141−100.0% | Sold out |